title: Method for retinal gene repair in neonatal mouse.
abstract: Gene correction at the site of the mutation in the chromosome is the absolute way to really cure a genetic disease. The oligonucleotide (ODN)-mediated gene repair technology uses an ODN perfectly complementary to the genomic sequence except for a mismatch at the base that is mutated. The endogenous repair machinery of the targeted cell then mediates substitution of the desired base in the gene, resulting in a completely normal sequence. Theoretically, it avoids potential gene silencing or random integration associated with common viral gene augmentation approaches and allows an intact regulation of expression of the therapeutic protein. The eye is a particularly attractive target for gene repair because of its unique features (small organ, easily accessible, low diffusion into systemic circulation). Moreover therapeutic effects on visual impairment could be obtained with modest levels of repair. This chapter describes in details the optimized method to target active ODNs to the nuclei of photoreceptors in neonatal mouse using (1) an electric current application at the eye surface (saline transpalpebral iontophoresis), (2) combined with an intravitreous injection of ODNs, as well as the experimental methods for (3) the dissection of adult neural retinas, (4) their immuno-labelling, and (5) flat-mounting for direct observation of photoreceptor survival, a relevant criteria of treatment outcomes for retinal degeneration.
authors.affiliation: INSERM, Centre de Recherche des Cordeliers, Université René Descartes Sorbonne Paris Cité, Paris, France.
authors.forename: Marilyn
authors.initials: M
authors.lastname: Dernigoghossian
authors.forename: Arthur
authors.initials: A
authors.lastname: Krigel
authors.forename: Francine
authors.initials: F
authors.lastname: Behar-Cohen
authors.forename: Charlotte
authors.initials: C
authors.lastname: Andrieu-Soler
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D051379:Mice; D009841:Oligonucleotides / Q000008:administration & dosage / Q000235:genetics*; D012160:Retina / Q000378:metabolism*; D012162:Retinal Degeneration / Q000235:genetics / Q000628:therapy
chemical_list: D009841:Oligonucleotides